Neuroone Medical Technologies (NMTC) Other Operating Expenses (2012 - 2026)

Neuroone Medical Technologies' Other Operating Expenses history runs 9 years deep, the most recent figure standing at $415795.0 for Q1 2026.

• Quarterly Other Operating Expenses changed N/A year-over-year to $415795.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $847034.0 (down 52.74% YoY) and the FY2024 annual result came in at $1.4 million, changed N/A from the prior year.
• Other Operating Expenses was $415795.0 for Q1 2026 at Neuroone Medical Technologies, down from $431239.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $1.4 million in Q3 2024 and bottomed at -$3.4 million in Q3 2022.
• A 4-year average of $72959.5 and a median of $423517.0 in 2025 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 10.83% in 2025, while the deepest fall reached 10.83% in 2025.
• Neuroone Medical Technologies' Other Operating Expenses stood at -$3.4 million in 2022, then surged by 111.55% to $389088.0 in 2024, then gained by 10.83% to $431239.0 in 2025, then retreated by 3.58% to $415795.0 in 2026.
• Business Quant data shows NMTC's Other Operating Expenses at $415795.0 in Q1 2026, $431239.0 in Q4 2025, and $389088.0 in Q4 2024.